Global CMO/CDMO Market Set for Steady Growth as Biologics Outsourcing and Specialized Manufacturing Drive Demand | Future Market Insights (FMI)

NEWARK, Del., April 14, 2026 /PRNewswire/ -- According to a latest market analysis by Future Market Insights, the global CMO/CDMO market is witnessing consistent expansion as pharmaceutical and biotech companies increasingly outsource development and manufacturing to focus on core competencies amid rising drug complexity and cost pressures. The CMO/CDMO Market was valued at USD 4.02 billion in 2025 and is projected to reach USD 5.46 billion by 2035, growing at a CAGR of 3.1% during the forecast period. Demand is being fueled by strong biologics and biosimilars pipelines, regulatory support for accelerated approvals, and the shift toward flexible, tech-enabled, and sustainable manufacturing solutions.

Quick Stats: CMO/CDMO Market

Detailed market forecasts, competitive benchmarking, and service trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-13038

Pricing Trends and Outsourcing Impact

 Procurement decisions in CMO/CDMO services are moving beyond cost-per-batch toward total value across the drug lifecycle. Sponsors now prioritize:

Advanced CDMOs offering continuous manufacturing, AI-driven process optimization, and single-use technologies are commanding premium positioning while delivering long-term cost efficiencies.

Installed Base and Capacity Expansion Demand

Pharmaceutical companies are increasingly relying on CDMOs for both clinical and commercial-scale production. Key drivers include:

New biologics facilities and expansions by leading CDMOs are supporting strong replacement and greenfield demand, especially in Asia-Pacific.

Production Capacity and Global Supply Chain 

Regional strengths differ markedly:

Key trends include supply chain diversification, nearshoring for critical therapies, and increased M&A activity to enhance capabilities in high-growth areas like cell and gene therapy.

Technology & Sustainability Adoption Across Services

CDMOs are integrating AI, digital twins, continuous manufacturing, and green chemistry protocols. Stand-alone services, integrated development, and regulatory assistance segments are seeing fastest adoption, enabling faster commercialization while meeting ESG goals.

Speak to Analyst: Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-13038

Key Buyers and Procurement Trends Main buyers include:

Buyers seek:

After-Sales Services and Operational Optimization

 Long-term success depends on strong client support including:

Regulations and Compliance

Stringent global standards continue to shape the market. CDMOs must maintain:

Companies with robust quality management systems and digital compliance tools are gaining preference.

Competitive Landscape

Leading companies such as Lonza Group, Catalent Inc., Samsung Biologics, WuXi AppTec, and Thermo Fisher Scientific (Patheon) are competing on:

The market is seeing consolidation as players expand specialized modalities and geographic reach.

Unlock 360° insights for strategic decision making and investment planning: https://www.futuremarketinsights.com/checkout/13038

Related Reports:

Peripheral Intravenous Catheter Market: https://www.futuremarketinsights.com/reports/peripheral-intravenous-catheter-market  

Peripherally Inserted Central Catheter Market: https://www.futuremarketinsights.com/reports/peripherally-inserted-central-catheters-market  

Venous Thromboembolism Treatment Market: https://www.futuremarketinsights.com/reports/venous-thromboembolism-treatment-market  

Central Dialysis Fluid Delivery System (CDDS) Market: https://www.futuremarketinsights.com/reports/central-dialysis-fluid-delivery-system-cdds-market  

Venous Stents Market: https://www.futuremarketinsights.com/reports/venous-stents-market  

About Future Market Insights (FMI) 

Future Market Insights (FMI) stands out by delivering actionable, decision-maker-focused research, not just data. Unlike traditional reports that focus only on market size and forecasts, FMI provides: 

FMI follows a bottom-up research approach, combining real industry inputs from procurement heads, technical experts, and supply chain leaders. This ensures that every insight is practical, validated, and business-ready. 

With a strong legacy in market intelligence, FMI is known for: 

FMI does what others don't—it connects data with real business decisions, helping companies plan investments, optimize costs, and stay ahead in competitive markets. 

For Press & Corporate Inquiries Rahul Singh AVP - Marketing and Growth Strategy Future Market Insights, Inc.                                                                                                      +91 8600020075 For Sales - [email protected] For Media - [email protected] For web - https://www.futuremarketinsights.com/

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

SOURCE Future Market Insights